Imagen de Google Jackets

Retinal Degenerative Diseases [electronic resource] / edited by Matthew M. LaVail, John D. Ash, Robert E. Anderson, Joe G. Hollyfield, Christian Grimm.

Por: Colaborador(es): Tipo de material: TextoTextoSeries Advances in Experimental Medicine and Biology ; 723 | Advances in Experimental Medicine and Biology ; 723Editor: Boston, MA : Springer US, 2012Descripción: LXIV, 864p. 196 illus., 88 illus. in color. online resourceTipo de contenido:
  • text
Tipo de medio:
  • computer
Tipo de soporte:
  • online resource
ISBN:
  • 9781461406310
Trabajos contenidos:
  • SpringerLink (Online service)
Tema(s): Formatos físicos adicionales: Sin títuloClasificación CDD:
  • 616.079 23
Clasificación LoC:
  • QR180-189.5
Recursos en línea: Springer eBooksResumen: This book will contain the proceedings of the XIV International Symposium on Retinal Degeneration (RD2010), held July 13-17, 2010, in Mont-Tremblant, Quebec, Canada. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy.
Etiquetas de esta biblioteca: No hay etiquetas de esta biblioteca para este título. Ingresar para agregar etiquetas.
Valoración
    Valoración media: 0.0 (0 votos)
No hay ítems correspondientes a este registro

This book will contain the proceedings of the XIV International Symposium on Retinal Degeneration (RD2010), held July 13-17, 2010, in Mont-Tremblant, Quebec, Canada. The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy.

ZDB-2-SBL

No hay comentarios en este titulo.

para colocar un comentario.